Global Medical and Health Communication
Vol. 13 No. 3 (2025): Accredited Sinta 2

Arcangelisia flava L. Merr. Aqueous Extract Potential as a Xanthine Oxidase Inhibitor

Fatmawati (Department of Biochemistry, Faculty of Medicine, Universitas Sriwijaya, Palembang)
Subandrate (Department of Biochemistry, Faculty of Medicine, Universitas Sriwijaya, Palembang)
Rini Yana (Department of Biochemistry, Faculty of Medicine, Universitas Sriwijaya, Palembang)
Maharani Puspita Sari HS (Medical Doctor Profession Study Program, Faculty of Medicine, Universitas Sriwijaya, Palembang)
Nadia Permata Sari (Medical Doctor Profession Program, Faculty of Medicine, Universitas Sriwijaya, Palembang)



Article Info

Publish Date
27 Dec 2025

Abstract

Arcangelisia flava L. Merr. contains several secondary metabolites, including berberine and palmatine, which are known to have potential as inhibitors of xanthine oxidase (XO). XO is an enzyme involved in purine metabolism, catalyzing the oxidation of hypoxanthine to xanthine and then xanthine to uric acid. The community uses the stems and leaves of A. flava to maintain health by brewing them in hot water. The potential of this plant to inhibit XO using an aqueous solvent has never been studied. This study aims to assess the xanthine oxidase inhibitory activity of water extracts derived from the stems and leaves of A. flava. The study design was an in vitro experimental study conducted in the Basic Medical Chemistry Laboratory of Universitas Sriwijaya from September to December 2023. The aqueous extract of stems and leaves from A. flava was tested using an in vitro xanthine oxidase inhibitory assay, as observed through a decrease in uric acid levels via UV absorption. The stem extract exhibited stronger XO inhibition (IC50=21.15 μg/ml, 95% CI=19.87–22.51) compared with the leaf extract (IC50=68.42 μg/ml, 95% CI=61.35–76.28). The inhibitory activity of the stem extract approached that of allopurinol (IC50=16.78 μg/ml, 95% CI=15.62–18.02). In conclusion, the aqueous stem extract of A. flava demonstrates significantly XO inhibitory activity than the aqueous leaf extract.

Copyrights © 2025






Journal Info

Abbrev

gmhc

Publisher

Subject

Description

Global Medical and Health Communication is a journal that publishes research articles on medical and health published every 4 (four) months (April, August, and December). Articles are original research that needs to be disseminated and written in English. Subjects suitable for publication include ...